Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Recruiting · NCT07014618 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Oklahoma
View the official record on ClinicalTrials.gov →Interventions studied
Opt Out of QuestionnairePre & Post Surveys
What this trial is about
The purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as their influence on adherence to standard of care treatment modalities.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Subjects must have histologically or cytologically confirmed Breast or Prostate Cancer.
- Subjects must be 18 years of age or older. This study requires informed consent by the subject.
- Subjects must be of African American race, Native American race, or Hispanic ethnicity.
- Subjects scheduled to undergo RT for Cancer Treatment.
- Subjects must have the ability to understand and the willingness to sign a written informed consent document.
Exclusion criteria
- Subjects NOT of African American race, Native American race or Hispanic ethnicity.
- Subjects WITHOUT histologically/cytologically confirmed Breast or Prostate Cancer.
- Subjects younger than 18 years old.
Where it is running
1 location listed across 1 US state.
- OU Health Stephenson Cancer Center - Oklahoma City, Oklahoma, United States